Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 25

1.

Key issues for estimating the impact and cost-effectiveness of seasonal influenza vaccination strategies.

Jit M, Newall AT, Beutels P.

Hum Vaccin Immunother. 2013 Apr;9(4):834-40. doi: 10.4161/hv.23637. Epub 2013 Jan 28. Review.

2.

Influenza cost and cost-effectiveness studies globally--a review.

Peasah SK, Azziz-Baumgartner E, Breese J, Meltzer MI, Widdowson MA.

Vaccine. 2013 Nov 4;31(46):5339-48. doi: 10.1016/j.vaccine.2013.09.013. Epub 2013 Sep 19. Review.

PMID:
24055351
3.

Economic evaluations of childhood influenza vaccination: a critical review.

Newall AT, Jit M, Beutels P.

Pharmacoeconomics. 2012 Aug 1;30(8):647-60. doi: 10.2165/11599130-000000000-00000. Review.

PMID:
22788257
4.

Key issues and challenges in estimating the impact and cost-effectiveness of quadrivalent influenza vaccination.

Quinn E, Jit M, Newall AT.

Expert Rev Pharmacoecon Outcomes Res. 2014 Jun;14(3):425-35. doi: 10.1586/14737167.2014.908713. Epub 2014 Apr 16. Review.

PMID:
24734967
5.

Review of seasonal influenza in Canada: Burden of disease and the cost-effectiveness of quadrivalent inactivated influenza vaccines.

Thommes EW, Kruse M, Kohli M, Sharma R, Noorduyn SG.

Hum Vaccin Immunother. 2017 Apr 3;13(4):867-876. doi: 10.1080/21645515.2016.1251537. Epub 2016 Nov 18. Review.

PMID:
27858509
6.

Cost-effectiveness and socio-economic aspects of childhood influenza vaccination.

Nichol KL.

Vaccine. 2011 Oct 6;29(43):7554-8. doi: 10.1016/j.vaccine.2011.08.015. Epub 2011 Aug 4. Review.

PMID:
21820477
7.

Seasonal influenza vaccination of healthy working-age adults: a review of economic evaluations.

Gatwood J, Meltzer MI, Messonnier M, Ortega-Sanchez IR, Balkrishnan R, Prosser LA.

Drugs. 2012 Jan 1;72(1):35-48. doi: 10.2165/11597310-000000000-00000. Review.

PMID:
22191794
8.

Pharmacoeconomics of influenza vaccination for healthy working adults: reviewing the available evidence.

Postma MJ, Jansema P, van Genugten ML, Heijnen ML, Jager JC, de Jong-van den Berg LT.

Drugs. 2002;62(7):1013-24. Review.

PMID:
11985488
9.

Influence of timing of seasonal influenza vaccination on effectiveness and cost-effectiveness in pregnancy.

Myers ER, Misurski DA, Swamy GK.

Am J Obstet Gynecol. 2011 Jun;204(6 Suppl 1):S128-40. doi: 10.1016/j.ajog.2011.04.009. Epub 2011 Apr 15. Review.

PMID:
21640230
10.

Antiviral agents for influenza: a comparison of cost-effectiveness data.

Lynd LD, Goeree R, O'Brien BJ.

Pharmacoeconomics. 2005;23(11):1083-106. Review.

PMID:
16277546
11.

Influenza vaccines in low and middle income countries: a systematic review of economic evaluations.

Ott JJ, Klein Breteler J, Tam JS, Hutubessy RC, Jit M, de Boer MR.

Hum Vaccin Immunother. 2013 Jul;9(7):1500-11. doi: 10.4161/hv.24704. Epub 2013 May 31. Review.

12.

Systematic review and economic decision modelling for the prevention and treatment of influenza A and B.

Turner D, Wailoo A, Nicholson K, Cooper N, Sutton A, Abrams K.

Health Technol Assess. 2003;7(35):iii-iv, xi-xiii, 1-170. Review.

13.

Clinical and socioeconomic impact of seasonal and pandemic influenza in adults and the elderly.

Gasparini R, Amicizia D, Lai PL, Panatto D.

Hum Vaccin Immunother. 2012 Jan;8(1):21-8. doi: 10.4161/hv.8.1.17622. Epub 2012 Jan 1. Review.

PMID:
22252007
14.

Economic evaluation of influenza vaccination. Assessment for The Netherlands.

Postma MJ, Bos JM, van Gennep M, Jager JC, Baltussen R, Sprenger MJ.

Pharmacoeconomics. 1999;16 Suppl 1:33-40. Review.

PMID:
10623374
15.
16.

Clinical and socioeconomic impact of pediatric seasonal and pandemic influenza.

Marchisio P, Baggi E, Bianchini S, Principi N, Esposito S.

Hum Vaccin Immunother. 2012 Jan;8(1):17-20. doi: 10.4161/hv.8.1.18145. Epub 2012 Jan 1. Review.

PMID:
22252002
17.

Seasonal influenza vaccines.

Fiore AE, Bridges CB, Cox NJ.

Curr Top Microbiol Immunol. 2009;333:43-82. doi: 10.1007/978-3-540-92165-3_3. Review.

PMID:
19768400
18.

Economic value of influenza vaccination.

de Waure C, Veneziano MA, Cadeddu C, Capizzi S, Specchia ML, Capri S, Ricciardi W.

Hum Vaccin Immunother. 2012 Jan;8(1):119-29. doi: 10.4161/hv.8.1.18420. Epub 2012 Jan 1. Review.

PMID:
22251999
19.

Cost effectiveness of influenza vaccination in older adults: a critical review of economic evaluations for the 50- to 64-year age group.

Newall AT, Kelly H, Harsley S, Scuffham PA.

Pharmacoeconomics. 2009;27(6):439-50. doi: 10.2165/00019053-200927060-00001. Review.

PMID:
19640008
20.

Evaluating the impact of influenza vaccination. A North American perspective.

Fedson DS.

Pharmacoeconomics. 1996;9 Suppl 3:54-61. Review.

PMID:
10160488

Supplemental Content

Support Center